Coin2Dose: Behavioral Economics to Promote Insulin BOLUS Activity and Improve HbA1c in Teens

Completed · Not applicable

Conditions studied: Type 1 Diabetes

In brief

Our objective is to test the feasibility, acceptability, and initial efficacy of using behavioral economics incentives (BEI) in a novel, semi-automated intervention to target daily insulin BOLUS scores in adolescents with suboptimal insulin use.

Key facts

Study ID

NCT05280184

Run by

Nemours Children's Clinic

People needed

173

Starts

2023-01-01

Expected to finish

2025-09-30

Last updated by the study team

2026-02-11

Who can join

Age: 11 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• adolescents between 11.0-17.0 years old and their parent/guardian;
• adolescents have a physician confirmed diagnosis of type 1 diabetes of at least 6 months duration;
• adolescents use an insulin pump for daily type 1 diabetes self-management;
• adolescents evidence sub-optimal daily BOLUS scores (a mean daily BOLUS score <2.5)

You may not qualify if…

• adolescents who do not use an insulin pump; adolescents who have an allergy or sensitivity to the adhesive and/or skin preparation used for CGM;
• adolescents with a comorbid chronic condition (e.g., renal disease);
• adolescents and parents who do not speak English

Where it is running

• Nemours Children's Health — Jacksonville, Florida, United States
• Children's Mercy Kansas City — Kansas City, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.